$BOLD
Boundless Bio, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$2.80
▼-0.71%-$0.020
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateBoundless Bio, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is BOLD down today? It is at $2.80 (-0.71%), and our scanner flagged it 3 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment BOLD spikes, and full due diligence on BOLD — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $BOLD 3 times in the last 30 days. Create a free account to track $BOLD, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on BOLD from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for BOLD today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystReverse stock split, from the latest SEC filing. Read it →Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Tang Kevin Beneficial Owner (10%) | Sold (automatic/other) | -18K 0.08% of company | sold 0.6% | 2.84M | $54K at $2.97 | Aug 26, 26 |
Tang Kevin Beneficial Owner (10%) | Bought (open market) | +3K 0.01% of company | added 0.1% | 2.86M | $7K at $2.44 | Jul 21, 26 |
Tang Kevin Beneficial Owner (10%) | Bought (open market) | +2K | added <0.1% | 2.86M | $4K at $2.44 | Jul 20, 26 |
Tang Kevin Beneficial Owner (10%) | Bought (open market) | +265 | added <0.1% | 2.85M | $647 at $2.44 | Jul 17, 26 |
Tang Kevin Beneficial Owner (10%) | Bought (open market) | +18K 0.08% of company | added 0.7% | 2.85M | $45K at $2.44 | Jul 16, 26 |
Tang Kevin Beneficial Owner (10%) | Bought (open market) | +2K | added <0.1% | 2.84M | $4K at $2.44 | Jul 15, 26 |
Tang Kevin Beneficial Owner (10%) | Bought (open market) | +44K 0.2% of company | added 1.6% | 2.83M | $107K at $2.43 | Jul 14, 26 |
Tang Kevin Beneficial Owner (10%) | Bought (open market) | +48K 0.2% of company | added 1.8% | 2.79M | $117K at $2.42 | Jul 13, 26 |
Tang Kevin Beneficial Owner (10%) | Bought (open market) | +43K 0.2% of company | added 1.6% | 2.74M | $105K at $2.43 | Jul 10, 26 |
Tang Kevin Beneficial Owner (10%) | Bought (open market) | +7 | added <0.1% | 2.70M | $17 at $2.48 | Jul 9, 26 |
Tang Kevin Beneficial Owner (10%) | Bought (open market) | +14K 0.06% of company | added 0.5% | 2.70M | $35K at $2.46 | Jul 8, 26 |
Tang Kevin Beneficial Owner (10%) | Bought (open market) | +16K 0.07% of company | added 0.6% | 2.68M | $39K at $2.48 | Jul 7, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on BOLD from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for BOLD today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
BOLD last traded at $2.80, down 0.71% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Boundless Bio, Inc. Common Stock (BOLD) is next expected to report earnings on Wednesday, November 4, 2026, about 47 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The BOLD Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged BOLD 3 times in the last 30 days.
BOLD (Boundless Bio, Inc. Common Stock) trades on XNAS, with a market cap of about $64M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge BOLD for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$BOLD discussion
Sign in to ask a question or join the discussion.